Medicare Advantage 2027: CMS Offers Gifts to Insurers, Pockets for Seniors

The Centers for Medicare & Medicaid Services (CMS) has finalized policies for the 2027 Medicare Advantage (MA) program that significantly increase payments to insurers, projected at a 2.48% net average increase, translating to over $13 billion in additional MA payments [c1, c2]. This financial boost comes as CMS keeps the 2024 MA risk adjustment model and excludes many unlinked chart review diagnoses from risk calculations

CMS finalized its 2027 Medicare Advantage and Part D payment policies, projecting a net average 2.48% increase, or more than $13B in additional MA payments. The agency will also keep the 2024 MA risk adjustment model and exclude most unlinked chart review diagnoses from risk…

— Wall St Engine link

. However, this financial largesse for the industry is coupled with a rollback of consumer protections. CMS is rescinding the requirement for MA plans to send mid-year notices about unused supplemental benefits, a move that could cause beneficiaries to miss out on valuable services [c5, c7]. Furthermore, marketing rules have been relaxed, including reduced call recording retention requirements and fewer restrictions on conversations with licensed agents [c5, c7]. While some transparency for Special Supplemental Benefits for the Chronically Ill is mandated, the elimination of mid-year notices and loosened marketing oversight raise concerns about whether seniors will truly benefit

"Several Medicare Advantage marketing protections were weakened, including reduced call recording retention requirements and relaxed marketing rules; The rule includes some positive changes to improve Part D formulary transparency and prior authorization oversight; Plans will be required to publish criteria for accessing supplemental benefits, but beneficiaries may still miss benefits because CMS eliminated proposed midyear notices."

.

The 2027 Medicare Advantage payment update is poised to deliver a substantial financial injection to health insurers. CMS has finalized a net average rate increase of 2.48%, which is projected to add over $13 billion in payments to MA plans [c1, c2]. This figure is significantly higher than some industry analysts anticipated, with some bracing for a mere 1.0% increase

Everything you need to know about the CMS news, and what it means for $UNH and $OSCR : $UNH surged after CMS finalized a much better-than-expected Medicare Advantage rate update for 2027. The headline rate came in at +2.48%, far above the +1.0% many were bracing for, and CMS…

— Stocker-Man link

. Adding to this windfall, CMS is simplifying the Star Ratings system, making it easier for plans to achieve bonus payments. Notably, 11 Star Rating metrics have been eliminated, and a planned health equity award has been scrapped

"In addition to the big rate increase, CMS also made it far easier for health insurers to increase their star ratings, which will trigger even more payments in bonuses for MA plans next year. CMS eliminated 11 star rating metrics and said it would not implement a new health equity award that had been put in place by the Biden administration and scheduled to go into effect in 2027."

. This financial surge is expected to directly benefit major MA players like UnitedHealth Group, Humana, and CVS Health

Medicare Advantage just got a massive cash injection 💰 Trump admin finalizes Star Ratings overhaul — $18B in extra payments flowing to health insurers. This is a direct tailwind for the big MA players: $UNH , $HUM , $CVS , $ELV , $CNC all stand to benefit from higher reimbursement…

— Casey | Trade Tracs link

.

While CMS claims to be enhancing consumer protections, the reality is more nuanced, with significant rollbacks in key areas. On the positive side, plans will be required to publish criteria for accessing supplemental benefits, aiming for greater transparency

"Several Medicare Advantage marketing protections were weakened, including reduced call recording retention requirements and relaxed marketing rules; The rule includes some positive changes to improve Part D formulary transparency and prior authorization oversight; Plans will be required to publish criteria for accessing supplemental benefits, but beneficiaries may still miss benefits because CMS eliminated proposed midyear notices."

. However, this is overshadowed by the elimination of mid-year notices that informed beneficiaries about unused supplemental benefits [c5, c7]. This means seniors might not be aware of all the services available to them, a critical oversight given the complexity of MA plans. Furthermore, marketing rules have been loosened. Restrictions on the time and manner of conversations between beneficiaries and licensed agents have been removed

"CMS is finalizing several changes to remove duplicative and burdensome regulatory requirements that have limited beneficiary choice, hindered innovation and increased costs: Rescinding the requirement for MA plans to send mid-year notices about unused supplemental benefits. ... Removing restrictions on the time and manner by which beneficiaries can have conversations with licensed agents and brokers."

, and call recording retention requirements have been reduced

"Several Medicare Advantage marketing protections were weakened, including reduced call recording retention requirements and relaxed marketing rules; The rule includes some positive changes to improve Part D formulary transparency and prior authorization oversight; Plans will be required to publish criteria for accessing supplemental benefits, but beneficiaries may still miss benefits because CMS eliminated proposed midyear notices."

. The agency's stated goal is to remove 'duplicative and burdensome regulatory requirements' that limit choice and innovation

"CMS is finalizing several changes to remove duplicative and burdensome regulatory requirements that have limited beneficiary choice, hindered innovation and increased costs: Rescinding the requirement for MA plans to send mid-year notices about unused supplemental benefits. ... Removing restrictions on the time and manner by which beneficiaries can have conversations with licensed agents and brokers."

, but critics argue this comes at the expense of informed decision-making for seniors

"In recent days, the Centers for Medicare & Medicaid Services (CMS) has issued policy – a Rate Notice and a final rule, both for 2027 – that significantly favor the Medicare Advantage (MA) industry, at the expense of both Medicare program finances and consumer protections."

.

The way Medicare Advantage plans are rated and rewarded is also undergoing significant change, with implications for both insurer revenue and beneficiary access. CMS has finalized what is being described as the biggest Star Ratings overhaul in a decade

"CMS finalized the biggest Stars overhaul in a decade, rolled back four health equity requirements, and added supplemental benefit rules that weren't even in the proposed rule."

. This includes eliminating several metrics and discontinuing a health equity award that was intended to incentivize better care for underserved populations

"In addition to the big rate increase, CMS also made it far easier for health insurers to increase their star ratings, which will trigger even more payments in bonuses for MA plans next year. CMS eliminated 11 star rating metrics and said it would not implement a new health equity award that had been put in place by the Biden administration and scheduled to go into effect in 2027."

. The rationale behind these changes, according to CMS, is to streamline requirements

"CMS is finalizing several changes to remove duplicative and burdensome regulatory requirements that have limited beneficiary choice, hindered innovation and increased costs: Rescinding the requirement for MA plans to send mid-year notices about unused supplemental benefits. ... Removing restrictions on the time and manner by which beneficiaries can have conversations with licensed agents and brokers."

. However, critics suggest this makes it easier for insurers to achieve higher Star Ratings, thereby qualifying for substantial bonus payments [c3, c8]. This system, which was already criticized for its complexity and potential for manipulation, now faces further scrutiny as it appears to favor increased insurer profitability over potentially more meaningful quality measures.